<qa>  What is the effect of anti-CTLA4 on the duration of in vivo persistenceII. Evaluate the influence of anti-CTLA4 ipilimumab on the duration of in vivo persistence and anti-tumor efficacy achieved following adoptive transfer of antigen-specific CTL. 